Publication:

CD1: From Molecules to Diseases

Loading...
Thumbnail Image

Open/View Files

Date

2017

Journal Title

Journal ISSN

Volume Title

Publisher

F1000Research
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Moody, D. Branch, and Sara Suliman. 2017. “CD1: From Molecules to Diseases.” F1000Research 6 (1): 1909. doi:10.12688/f1000research.12178.1. http://dx.doi.org/10.12688/f1000research.12178.1.

Abstract

The human cluster of differentiation (CD)1 system for antigen display is comprised of four types of antigen-presenting molecules, each with a distinct functional niche: CD1a, CD1b, CD1c, and CD1d. Whereas CD1 proteins were thought solely to influence T-cell responses through display of amphipathic lipids, recent studies emphasize the role of direct contacts between the T-cell receptor and CD1 itself. Moving from molecules to diseases, new research approaches emphasize human CD1-transgenic mouse models and the study of human polyclonal T cells in vivo or ex vivo in disease states. Whereas the high genetic diversity of major histocompatibility complex (MHC)-encoded antigen-presenting molecules provides a major hurdle for designing antigens that activate T cells in all humans, the simple population genetics of the CD1 system offers the prospect of discovering or designing broadly acting immunomodulatory agents.

Description

Research Data

Keywords

Articles, Antigen Processing & Recognition, Immunity to Infections, Immunomodulation, Innate Immunity, Leukocyte Signaling & Gene Expression, Medical Microbiology, CD1, antigen display, TCR, T cell receptor

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories